Ulf Grawunder
Direttore/Membro del Consiglio presso WUXI XDC CAYMAN INC.
Posizioni attive di Ulf Grawunder
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| WUXI XDC CAYMAN INC. | Direttore/Membro del Consiglio | - | - |
| Independent Dir/Board Member | - | - | |
| ADAGENE INC. | Direttore/Membro del Consiglio | 01/04/2024 | - |
| Independent Dir/Board Member | 01/04/2024 | - | |
NBE-Therapeutics AG
 NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Direttore/Membro del Consiglio | 18/04/2012 | - |
| Direttore operativo | 03/08/2020 | - | |
| Fondatore | 18/04/2012 | - | |
| Amministratore Delegato | 18/04/2012 | 03/08/2020 | |
| T-CURX GmbH | Amministratore Delegato | 01/09/2022 | - |
| Fondatore | 01/09/2022 | - | |
Viopas Venture Consulting GmbH
 Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland. | Corporate Officer/Principal | 01/01/2022 | - |
Storia della carriera di Ulf Grawunder
Precedenti posizioni note di Ulf Grawunder
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - | - |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Direttore Tecnico/Scientifico/R&S | 12/12/2002 | - |
| Fondatore | 17/07/2009 | - |
Formazione di Ulf Grawunder
| University of Basel | Doctorate Degree |
| University of Bayreuth | Graduate Degree |
Statistiche
Distribuzione geografica
| Svizzera | 5 |
| Germania | 3 |
| Stati Uniti | 2 |
Posizioni
| Founder | 3 |
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| WUXI XDC CAYMAN INC. | Commercial Services |
| ADAGENE INC. | Health Technology |
| Aziende private | 4 |
|---|---|
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Health Technology |
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Health Technology |
| T-CURX GmbH | |
Viopas Venture Consulting GmbH
Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland. | Finance |
- Borsa valori
- Insiders
- Ulf Grawunder
- Esperienza
